Stryphnodendron Adstringens Intimate Soap

- Active and regular menstrual flow;

- Vaginal pH value between 3.8 and 4.5;

- Intact skin in the product analysis region (vaginal mucosa);

- Being a user of cosmetic products of the same category (intimate soap);

- Agreement to follow the trial procedures and attendance at the Clinical Research Center on the days and times determined for applications and/or estimates;

- Understanding, consent and signature of the Free and Informed Consent Term (TCLE).

- Participants who have been diagnosed with COVID-19 in the last 4 weeks or who have symptoms such as fever, dry cough, tiredness, body aches or other discomforts;

- Pregnancy or risk of pregnancy and/or lactation;

- Being in the menstrual period;

- Use of anti-inflammatory/immunosuppressive/antihistamine drugs up to 3 weeks before selection;

- Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (vascular malformations, scars, increased hairiness, large amounts of nevus, sunburn);

- Atopic or allergic history to cosmetic products;

- Pathologies and/or active skin lesions (local and/or disseminated) in the evaluation area;

- Immunosuppression by drugs or active diseases;

- Decompensated endocrinopathies;

- Relevant medical history or current evidence of alcohol or other drug abuse;

- Known history or suspected intolerance to products of the same category;

- Aesthetic or dermatological treatment in the evaluation area up to 04 weeks before selection;

- Employees of Medcin or the sponsoring company involved in the study, or a close family member of an employee involved in the study;

- Other conditions considered by the researcher as reasonable for disqualification from participation in the study. If yes, it should be described in observation in the clinical record.